GetTopicDetailResponse(id=2b7f8442613, topicName=脂質體伊立替康, introduction=脂質體伊立替康, content=null, image=null, comments=3, allHits=1912, url=https://h5.medsci.cn/topic?id=84426, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=91871, tagList=[TagDto(tagId=91871, tagName=脂質體伊立替康)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2205358, encodeId=e5972205358b1, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=1c855620260' target=_blank style='color:#2F92EE;'>#拓撲替康#</a> <a href='/topic/show?id=2b7f8442613' target=_blank style='color:#2F92EE;'>#脂質體伊立替康#</a>, objectTitle=JCO | 脂質體伊立替康與拓樸替康治療成人復發(fā)性小細胞肺癌的隨機、開放標簽Ⅲ期臨床研究, objectType=article, longId=826358, objectId=d2c58263580e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715955785430_6145188.png, objectUrl=/article/show_article.do?id=d2c58263580e, replyNumber=0, likeNumber=108, createdTime=2024-05-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d2c58263580e, moduleTitle=JCO | 脂質體伊立替康與拓樸替康治療成人復發(fā)性小細胞肺癌的隨機、開放標簽Ⅲ期臨床研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d2c58263580e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1299407, encodeId=6b9c129940efa, content=<a href='/topic/show?id=2b7f8442613' target=_blank style='color:#2F92EE;'>#脂質體伊立替康#</a>, objectTitle=Lancet Oncol：脂質體伊立替康聯(lián)合亞葉酸和氟尿嘧啶或可成為晚期膽道癌的二線標準治療方案！, objectType=article, longId=219153, objectId=574821915388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574821915388, replyNumber=0, likeNumber=107, createdTime=2021-10-25, rootId=0, userName=shalley66, userId=f378286, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574821915388, moduleTitle=Lancet Oncol：脂質體伊立替康聯(lián)合亞葉酸和氟尿嘧啶或可成為晚期膽道癌的二線標準治療方案！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=574821915388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1299406, encodeId=63281299406fd, content=<a href='/topic/show?id=2b7f8442613' target=_blank style='color:#2F92EE;'>#脂質體伊立替康#</a>, objectTitle=WCLC 2019：評估脂質體伊立替康（ONIVYDE）作為小細胞肺癌的二線療法, objectType=article, longId=179176, objectId=99521e9176c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99521e9176c4, replyNumber=0, likeNumber=93, createdTime=2019-09-10, rootId=0, userName=shalley66, userId=f378286, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99521e9176c4, moduleTitle=WCLC 2019：評估脂質體伊立替康（ONIVYDE）作為小細胞肺癌的二線療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=99521e9176c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1299405, encodeId=dc741299405f5, content=<a href='/topic/show?id=2b7f8442613' target=_blank style='color:#2F92EE;'>#脂質體伊立替康#</a>, objectTitle=ESMO世界胃腸癌大會：評估脂質體伊立替康作為轉移性胰腺癌一線療法的I/II期臨床研究, objectType=article, longId=174987, objectId=88ee1e49876f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ee1e49876f, replyNumber=0, likeNumber=87, createdTime=2019-07-09, rootId=0, userName=shalley66, userId=f378286, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ee1e49876f, moduleTitle=ESMO世界胃腸癌大會：評估脂質體伊立替康作為轉移性胰腺癌一線療法的I/II期臨床研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=88ee1e49876f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
